- EXCLUSIVE OFFER: Jim Cramer's Protégé, Dave Peltier, only buys Stocks Under $10 that he thinks could potentially double. See what he's trading today with a 14-day FREE pass.
- You can view the full Merck Ratings Report.
TheStreet's Adam Feuerstein answers reader questions about biotech stocks.
There is no shortage of opinions and politics as the House prepares for a vote Nov. 30 on 21st Century Cures Act.